Maynard Um
-
-
-
-
-
-
-
Oppenheimer Reiterates CalciMedica (CALC) at Outperform, 'We would build a position'
-
-
-
-
-
-
-
CalciMedica (CALC) Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora
-
-
-
-
-
-
-
CalciMedica (CALC) Misses Q2 EPS by 36c
-
-
-
-
-
-
434,328 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

